In the previous articles of our Beyond FDA series, we explored five realities that many Healthcare AI companies discover too late: FDA clearance does not guarantee market adoption. Great products fail without a reimbursement strategy. AI accuracy alone is no longer enough. Clinical validation is what earns trust. Trust itself comes from Key Opinion Leaders, not marketing. And clearance, validation, and adoption are three separate pillars that must be earned independently. This brings us to the start of a new phase in the series, one focused on what it actually takes to operate inside enterprise healthcare: The best algorithm in the world still loses to the best-integrated one.
The Uncomfortable Truth About Algorithm Quality
Most Healthcare AI companies compete on the same axis: accuracy, sensitivity, AUC. But once a product reaches actual hospital evaluation, a different question takes over almost immediately:
"How does this actually sit inside our systems?"
A superior algorithm that requires manual file transfers, custom middleware, or IT exceptions will consistently lose a deal to a slightly less accurate one that simply works inside the hospital's existing PACS, RIS, and EHR, with no extra lift from already-stretched IT teams.
What "Interoperable" Actually Means
Interoperability isn't a buzzword: it's a specific, testable set of technical requirements:
✔ DICOM compatibility: the AI reads and writes images in the format radiology already uses
✔ PACS/RIS integration: results appear inside the existing viewer and worklist, not a separate login
✔ HL7/FHIR support: structured data flows into the EHR instead of living in a silo
✔ Vendor-neutral deployment: the tool doesn't require a single proprietary ecosystem to function
Every one of these is invisible to a demo audience and decisive to an IT review board.
Why This Gets Underestimated
Founders building a novel algorithm naturally focus their engineering effort on the model. Integration work often gets treated as an afterthought. Something to solve "once we have a customer."
But hospitals don't experience your algorithm in isolation. They experience it as one more thing their radiologists have to click into, their IT team has to secure, and their PACS administrator has to maintain. If that experience is friction-heavy, no amount of clinical accuracy recovers the deal.
The Companies That Get This Right
The Healthcare AI companies that scale fastest in the U.S. treat interoperability as a product feature, not an IT afterthought:
-
They build DICOM and HL7/FHIR support before their first hospital pilot, not after
-
They design results to appear inside the radiologist's existing worklist, not a separate app
-
They can answer PACS/EHR integration questions confidently in the first sales call, because it's already solved
This isn't the exciting part of building Healthcare AI. It's the part that determines whether the exciting part ever reaches a patient.
Final Thought
Radiologists don't want another system to check. IT departments don't want another exception to manage. And hospitals don't want a pilot that dies in a queue of integration tickets.
Great AI gets attention.
Seamless integration gets adopted.
The best AI in Healthcare isn't the one people talk about: it's the one nobody notices, because it simply works inside the systems already in place.
Next in the Beyond FDA Series:
Why CIOs Buy Integration Before Innovation
#HealthcareAI #Interoperability #PACS #EHR #FHIR #DICOM #DigitalHealth #HealthcareInnovation #ArtificialIntelligence #MedTech #SaMD #RadiologyAI #QscriptionTechnologies